Rohit Kumar

Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.

D. Ettinger, A. Leung, E. Kazerooni, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Lung Cancer Screening Beyond Low-Dose Computed Tomography: The Role of Novel Biomarkers

Naveed Hasan, M. Kavuru, Rohit Kumar, 2014, Lung.

Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines.

Matthew B Schabath, Pierre P Massion, Mary E Reid, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022.

D. Ettinger, A. Leung, E. Kazerooni, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Prediction of lung cancer immunotherapy response via machine learning analysis of immune cell lineage and surface markers.

Xiaoling Hu, Rohit Kumar, Jun-Hai Yan, 2022, Cancer biomarkers : section A of Disease markers.

NCCN Lung Cancer Screening , Version 3 . 2018 Clinical Practice Guidelines in Oncology

D. Ettinger, A. Leung, E. Kazerooni, 2018 .

NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022

D. Ettinger, A. Leung, E. Kazerooni, 2022, The Journal of the National Comprehensive Cancer Network.